Using structural MRI to identify bipolar disorders – 13 site machine learning study in 3020 individuals from the ENIGMA Bipolar Disorders Working Group
-
Published:2018-08-31
Issue:9
Volume:25
Page:2130-2143
-
ISSN:1359-4184
-
Container-title:Molecular Psychiatry
-
language:en
-
Short-container-title:Mol Psychiatry
Author:
Nunes Abraham, , Schnack Hugo G., Ching Christopher R. K., Agartz Ingrid, Akudjedu Theophilus N.ORCID, Alda Martin, Alnæs DagORCID, Alonso-Lana SilviaORCID, Bauer Jochen, Baune Bernhard T.ORCID, Bøen Erlend, Bonnin Caterina del Mar, Busatto Geraldo F., Canales-Rodríguez Erick J., Cannon Dara M., Caseras Xavier, Chaim-Avancini Tiffany M., Dannlowski Udo, Díaz-Zuluaga Ana M., Dietsche Bruno, Doan Nhat Trung, Duchesnay EdouardORCID, Elvsåshagen Torbjørn, Emden Daniel, Eyler Lisa T.ORCID, Fatjó-Vilas Mar, Favre Pauline, Foley Sonya F., Fullerton Janice M.ORCID, Glahn David C.ORCID, Goikolea Jose M., Grotegerd Dominik, Hahn Tim, Henry Chantal, Hibar Derrek P., Houenou Josselin, Howells Fleur M., Jahanshad Neda, Kaufmann Tobias, Kenney JoanneORCID, Kircher Tilo T. J., Krug Axel, Lagerberg Trine V., Lenroot Rhoshel K., López-Jaramillo Carlos, Machado-Vieira Rodrigo, Malt Ulrik F., McDonald Colm, Mitchell Philip B., Mwangi Benson, Nabulsi LeilaORCID, Opel Nils, Overs Bronwyn J., Pineda-Zapata Julian A., Pomarol-Clotet Edith, Redlich Ronny, Roberts Gloria, Rosa Pedro G., Salvador Raymond, Satterthwaite Theodore D.ORCID, Soares Jair C., Stein Dan J., Temmingh Henk S., Trappenberg Thomas, Uhlmann Anne, van Haren Neeltje E. M., Vieta Eduard, Westlye Lars T.ORCID, Wolf Daniel H., Yüksel Dilara, Zanetti Marcus V., Andreassen Ole A.ORCID, Thompson Paul M., Hajek Tomas
Abstract
AbstractBipolar disorders (BDs) are among the leading causes of morbidity and disability. Objective biological markers, such as those based on brain imaging, could aid in clinical management of BD. Machine learning (ML) brings neuroimaging analyses to individual subject level and may potentially allow for their diagnostic use. However, fair and optimal application of ML requires large, multi-site datasets. We applied ML (support vector machines) to MRI data (regional cortical thickness, surface area, subcortical volumes) from 853 BD and 2167 control participants from 13 cohorts in the ENIGMA consortium. We attempted to differentiate BD from control participants, investigated different data handling strategies and studied the neuroimaging/clinical features most important for classification. Individual site accuracies ranged from 45.23% to 81.07%. Aggregate subject-level analyses yielded the highest accuracy (65.23%, 95% CI = 63.47–67.00, ROC-AUC = 71.49%, 95% CI = 69.39–73.59), followed by leave-one-site-out cross-validation (accuracy = 58.67%, 95% CI = 56.70–60.63). Meta-analysis of individual site accuracies did not provide above chance results. There was substantial agreement between the regions that contributed to identification of BD participants in the best performing site and in the aggregate dataset (Cohen’s Kappa = 0.83, 95% CI = 0.829–0.831). Treatment with anticonvulsants and age were associated with greater odds of correct classification. Although short of the 80% clinically relevant accuracy threshold, the results are promising and provide a fair and realistic estimate of classification performance, which can be achieved in a large, ecologically valid, multi-site sample of BD participants based on regional neurostructural measures. Furthermore, the significant classification in different samples was based on plausible and similar neuroanatomical features. Future multi-site studies should move towards sharing of raw/voxelwise neuroimaging data.
Publisher
Springer Science and Business Media LLC
Subject
Cellular and Molecular Neuroscience,Psychiatry and Mental health,Molecular Biology
Reference78 articles.
1. Gustavsson A, Svensson M, Jacobi F, Allgulander C, Alonso J, Beghi E, et al. Cost of disorders of the brain in Europe 2010. Eur Neuropsychopharmacol. 2011;21:718–79. 2. Whiteford HA, Degenhardt L, Rehm J, Baxter AJ, Ferrari AJ, Erskine HE, et al. Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010. Lancet. 2013;382:1575–86. 3. Bschor T, Angst J, Azorin JM, Bowden CL, Perugi G, Vieta E, et al. Are bipolar disorders underdiagnosed in patients with depressive episodes? Results of the multicenter BRIDGE screening study in Germany. J Affect Disord. 2012;142:45–52. 4. Ghaemi SN, Sachs GS, Chiou AM, Pandurangi AK, Goodwin K. Is bipolar disorder still underdiagnosed? Are antidepressants overutilized? J Affect Disord. 1999;52:135–44. 5. Duffy A, Alda M, Hajek T, Grof P. Early course of bipolar disorder in high-risk offspring: prospective study. Br J Psychiatry. 2009;195:457–8.
Cited by
120 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|